UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Ingredient",
"id" : "TPTDteva-2080-Solution-SE-IS-ING",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Ingredient TPTDteva-2080-Solution-SE-IS-ING</b></p><a name=\"TPTDteva-2080-Solution-SE-IS-ING\"> </a><a name=\"hcTPTDteva-2080-Solution-SE-IS-ING\"> </a><a name=\"hcTPTDteva-2080-Solution-SE-IS-ING-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-TPTDteva-2080-Solution-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00053004,http://ema.europa.eu/fhir/eurdId#2903; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in pre-filled pen; indication = Teriparatide Teva är avsett för vuxna. Behandling av osteoporos hos postmenopausala kvinnor och hos män med ökad risk för frakturer (se avsnitt 5.1). Incidensen vertebrala och icke-vertebrala frakturer reduceras signifikant hos postmenopausala kvinnor men detta har ej visats för höftfrakturer. Behandling av osteoporos i samband med kronisk systemisk glukokortikoidbehandling hos kvinnor och män med ökad risk för frakturer (se avsnitt 5.1).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = H05AA02</a></li><li><a href=\"ManufacturedItemDefinition-TPTDteva-2080-Solution-SE-IS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection in pre-filled pen; unitOfPresentation = Pen</a></li><li><a href=\"AdministrableProductDefinition-TPTDteva-2080-Solution-SE-IS-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Solution for injection</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000089193}\">Teriparatide</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>concentration</b>: 0.25 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 milliliter(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110662 = '100000110662')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000089193}\">Teriparatide</span></td></tr></table><p><b>strength</b>: 0.25 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 milliliter(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110662 = '100000110662')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/TPTDteva-2080-Solution-SE-IS-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/TPTDteva-2080-Solution-SE-IS-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/TPTDteva-2080-Solution-SE-IS-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000089193",
"display" : "Teriparatide"
}
]
}
},
"strength" : [
{
"concentrationRatio" : {
"numerator" : {
"value" : 0.25,
"unit" : "milligram(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "milliliter(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000089193",
"display" : "Teriparatide"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 0.25,
"unit" : "milligram(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "milliliter(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110662"
}
}
}
]
}
]
}
}